NTG CLARITY NETWORKS INC (NCI.CA) Stock Fundamental Analysis

TSX-V:NCI • CA62940V2030

1.07 CAD
-0.07 (-6.14%)
Last: Feb 13, 2026, 07:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to NCI. NCI was compared to 69 industry peers in the Software industry. NCI has an average financial health and profitability rating. NCI is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make NCI suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year NCI was profitable.
  • In the past year NCI has reported a negative cash flow from operations.
  • NCI had positive earnings in 4 of the past 5 years.
  • NCI had a positive operating cash flow in each of the past 5 years.
NCI.CA Yearly Net Income VS EBIT VS OCF VS FCFNCI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

  • The Return On Assets of NCI (17.08%) is better than 92.54% of its industry peers.
  • NCI has a better Return On Equity (28.01%) than 92.54% of its industry peers.
  • NCI has a Return On Invested Capital of 23.79%. This is amongst the best in the industry. NCI outperforms 95.52% of its industry peers.
Industry RankSector Rank
ROA 17.08%
ROE 28.01%
ROIC 23.79%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NCI.CA Yearly ROA, ROE, ROICNCI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

  • Looking at the Profit Margin, with a value of 9.85%, NCI belongs to the top of the industry, outperforming 80.60% of the companies in the same industry.
  • NCI's Profit Margin has improved in the last couple of years.
  • The Operating Margin of NCI (13.86%) is better than 79.10% of its industry peers.
  • In the last couple of years the Operating Margin of NCI has declined.
  • Looking at the Gross Margin, with a value of 35.76%, NCI is doing worse than 62.69% of the companies in the same industry.
  • NCI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.86%
PM (TTM) 9.85%
GM 35.76%
OM growth 3Y-3.27%
OM growth 5YN/A
PM growth 3Y14.92%
PM growth 5YN/A
GM growth 3Y-12.47%
GM growth 5Y7.3%
NCI.CA Yearly Profit, Operating, Gross MarginsNCI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

6

2. Health

2.1 Basic Checks

  • NCI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, NCI has more shares outstanding
  • Compared to 5 years ago, NCI has more shares outstanding
  • Compared to 1 year ago, NCI has an improved debt to assets ratio.
NCI.CA Yearly Shares OutstandingNCI.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2023 2024 50M 100M
NCI.CA Yearly Total Debt VS Total AssetsNCI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • NCI has an Altman-Z score of 4.89. This indicates that NCI is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of NCI (4.89) is better than 79.10% of its industry peers.
  • NCI has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
  • NCI has a Debt to Equity ratio (0.19) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z 4.89
ROIC/WACC2.34
WACC10.17%
NCI.CA Yearly LT Debt VS Equity VS FCFNCI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

2.3 Liquidity

  • NCI has a Current Ratio of 3.13. This indicates that NCI is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 3.13, NCI is in the better half of the industry, outperforming 77.61% of the companies in the same industry.
  • A Quick Ratio of 3.13 indicates that NCI has no problem at all paying its short term obligations.
  • The Quick ratio of NCI (3.13) is better than 79.10% of its industry peers.
Industry RankSector Rank
Current Ratio 3.13
Quick Ratio 3.13
NCI.CA Yearly Current Assets VS Current LiabilitesNCI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2023 2024 5M 10M 15M 20M

8

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 15.26% over the past year.
  • Measured over the past years, NCI shows a very strong growth in Earnings Per Share. The EPS has been growing by 68.04% on average per year.
  • The Revenue has grown by 62.61% in the past year. This is a very strong growth!
  • Measured over the past years, NCI shows a very strong growth in Revenue. The Revenue has been growing by 45.43% on average per year.
EPS 1Y (TTM)15.26%
EPS 3Y68.04%
EPS 5YN/A
EPS Q2Q%-15.85%
Revenue 1Y (TTM)62.61%
Revenue growth 3Y67.72%
Revenue growth 5Y45.43%
Sales Q2Q%42.22%

3.2 Future

  • NCI is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.23% yearly.
  • Based on estimates for the next years, NCI will show a very strong growth in Revenue. The Revenue will grow by 31.35% on average per year.
EPS Next Y-34.96%
EPS Next 2Y-1.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year46.65%
Revenue Next 2Y31.35%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
NCI.CA Yearly Revenue VS EstimatesNCI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
NCI.CA Yearly EPS VS EstimatesNCI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.05 0.1 0.15

6

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 7.64, the valuation of NCI can be described as very cheap.
  • 88.06% of the companies in the same industry are more expensive than NCI, based on the Price/Earnings ratio.
  • NCI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.68.
  • A Price/Forward Earnings ratio of 5.77 indicates a rather cheap valuation of NCI.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of NCI indicates a rather cheap valuation: NCI is cheaper than 88.06% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, NCI is valued rather cheaply.
Industry RankSector Rank
PE 7.64
Fwd PE 5.77
NCI.CA Price Earnings VS Forward Price EarningsNCI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NCI is valued cheaper than 82.09% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.22
NCI.CA Per share dataNCI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • The decent profitability rating of NCI may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.23%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • NCI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

NTG CLARITY NETWORKS INC

TSX-V:NCI (2/13/2026, 7:00:00 PM)

1.07

-0.07 (-6.14%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-12
Earnings (Next)N/A
Inst Owners0.35%
Inst Owner ChangeN/A
Ins Owners24.52%
Ins Owner ChangeN/A
Market Cap51.11M
Revenue(TTM)76.65M
Net Income(TTM)7.55M
Analysts84
Price Target4.05 (278.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-59.73%
Min EPS beat(2)-85.29%
Max EPS beat(2)-34.18%
EPS beat(4)1
Avg EPS beat(4)-14.44%
Min EPS beat(4)-85.29%
Max EPS beat(4)94.17%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.48%
Min Revenue beat(2)-5.69%
Max Revenue beat(2)0.73%
Revenue beat(4)3
Avg Revenue beat(4)1.13%
Min Revenue beat(4)-5.69%
Max Revenue beat(4)8.23%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-4.8%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-42.86%
EPS NY rev (1m)-40%
EPS NY rev (3m)-43.75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.33%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.75%
Valuation
Industry RankSector Rank
PE 7.64
Fwd PE 5.77
P/S 0.67
P/FCF N/A
P/OCF N/A
P/B 1.9
P/tB 2.18
EV/EBITDA 4.22
EPS(TTM)0.14
EY13.08%
EPS(NY)0.19
Fwd EY17.33%
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS1.6
BVpS0.56
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.33
Profitability
Industry RankSector Rank
ROA 17.08%
ROE 28.01%
ROCE 33.04%
ROIC 23.79%
ROICexc 29.91%
ROICexgc 34.7%
OM 13.86%
PM (TTM) 9.85%
GM 35.76%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.27%
OM growth 5YN/A
PM growth 3Y14.92%
PM growth 5YN/A
GM growth 3Y-12.47%
GM growth 5Y7.3%
F-Score5
Asset Turnover1.73
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA 0.43
Cap/Depr 101.9%
Cap/Sales 1.94%
Interest Coverage 31.2
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.13
Quick Ratio 3.13
Altman-Z 4.89
F-Score5
WACC10.17%
ROIC/WACC2.34
Cap/Depr(3y)274.99%
Cap/Depr(5y)720.23%
Cap/Sales(3y)6.12%
Cap/Sales(5y)8.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.26%
EPS 3Y68.04%
EPS 5YN/A
EPS Q2Q%-15.85%
EPS Next Y-34.96%
EPS Next 2Y-1.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)62.61%
Revenue growth 3Y67.72%
Revenue growth 5Y45.43%
Sales Q2Q%42.22%
Revenue Next Year46.65%
Revenue Next 2Y31.35%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y53.89%
EBIT growth 3Y62.24%
EBIT growth 5YN/A
EBIT Next Year20.38%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1129.52%
FCF growth 3Y85.08%
FCF growth 5YN/A
OCF growth 1Y-287.68%
OCF growth 3Y12.61%
OCF growth 5Y234.98%

NTG CLARITY NETWORKS INC / NCI.CA FAQ

What is the fundamental rating for NCI stock?

ChartMill assigns a fundamental rating of 6 / 10 to NCI.CA.


What is the valuation status for NCI stock?

ChartMill assigns a valuation rating of 6 / 10 to NTG CLARITY NETWORKS INC (NCI.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for NTG CLARITY NETWORKS INC?

NTG CLARITY NETWORKS INC (NCI.CA) has a profitability rating of 6 / 10.


What is the expected EPS growth for NTG CLARITY NETWORKS INC (NCI.CA) stock?

The Earnings per Share (EPS) of NTG CLARITY NETWORKS INC (NCI.CA) is expected to decline by -34.96% in the next year.